ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,899,000 | -90.7% | 284,853 | -91.0% | 0.14% | -75.8% |
| Q4 2021 | $73,944,000 | +103.2% | 3,168,104 | +124.6% | 0.57% | +23.9% |
| Q1 2021 | $36,386,000 | +7449.0% | 1,410,305 | +12429.4% | 0.46% | +4500.0% |
| Q4 2019 | $482,000 | +20.5% | 11,256 | -24.4% | 0.01% | -9.1% |
| Q1 2019 | $400,000 | -93.5% | 14,897 | -94.6% | 0.01% | -93.6% |
| Q1 2018 | $6,179,000 | +88171.4% | 275,000 | +175.0% | 0.17% | – |
| Q4 2016 | $7,000 | -99.7% | 100,000 | +53.3% | 0.00% | -100.0% |
| Q3 2016 | $2,075,000 | -79.1% | 65,240 | -85.7% | 0.13% | -84.6% |
| Q1 2016 | $9,933,000 | -49.2% | 455,240 | -24.2% | 0.87% | -42.7% |
| Q1 2015 | $19,562,000 | -43.6% | 600,240 | -45.1% | 1.52% | -47.8% |
| Q4 2014 | $34,712,000 | +27.7% | 1,093,281 | -0.4% | 2.91% | -0.3% |
| Q3 2014 | $27,184,000 | +84.3% | 1,097,914 | +68.1% | 2.92% | +101.7% |
| Q2 2014 | $14,751,000 | -9.0% | 653,000 | -2.0% | 1.45% | -15.0% |
| Q1 2014 | $16,204,000 | -51.7% | 666,000 | -45.5% | 1.70% | +23.3% |
| Q3 2013 | $33,548,000 | +154.4% | 1,221,230 | +68.1% | 1.38% | +3.8% |
| Q2 2013 | $13,188,000 | – | 726,629 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |